Gain-of-function mutations in the KRAS gene are among the most common genetic alterations in CCA, occurring in approximately 15–25% of iCCA cases and up to ~40% of pCCA and dCCA cases [94,136,137]. Here, KRAS is linked to cholangiocarcinoma.